City

Little Rock (1)

Santiago (1)

Zurich (1)

Condition

Immune Senescence (3)

Low-grade Inflammation (1)

Sarcopenia (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

n/a (2)

phase 4 (1)

Sponsor

University of Arkansas (1)

University of Chile (1)

University of Zurich (1)

Collaborator

Division of Infectious Diseases and Hospital Epidemiology (1)

Nestle (1)

Intervention

fully torrefied coffee (1)

oral ps-ipc supplement (1)

partially torrefied coffee (1)

placebo supplement (1)

vaccination against tbev (fsme immun cc) (1)

Study Documents

Intervention Type

dietary supplement (2)

biological (1)

Funder Type

Other (3)

Study Type

Interventional (3)

immune senescence

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Immune Senescence, Low-grade Inflammation Trial in Santiago (Fully torrefied coffee, Partially torrefied coffee)

Completed

Immune Senescence
Low-grade Inflammation

Fully torrefied coffee
Partially torrefied coffee

Santiago, Metropolitana, Chile

INTA University of Chile

Nov 30, 2015

Immune Senescence Trial in Zurich (Vaccination against TBEV (FSME Immun CC))

Completed

Immune Senescence

Vaccination against TBEV (FSME Immun CC)

Zurich, Switzerland

University Hospital Zurich, Department of Infectious Diseases an

Aug 26, 2013

Immune Senescence, Sarcopenia Trial in Little Rock (Oral PS-IPC supplement, Placebo supplement)

Terminated

Immune Senescence
Sarcopenia

Oral PS-IPC supplement
Placebo supplement

Little Rock, Arkansas

University of Arkansas for Medical Sciences

Jan 17, 2012